Her2 Ventana Medical Systems

VENTANA anti-HER2/neu (4B5) Rabbit Monoclonal …

https://diagnostics.roche.com/global/en/products/tests/ventana-anti-her2-neu-4b5-rabbit-monoclonal-primary-antibody-ce-ivd.html

The use of pre-diluted VENTANA anti-HER2/neu (4B5) Rabbit Monoclonal Primary Antibody 1 (VENTANA HER2 (4B5) Antibody), in combination with the fully automated …

PATHWAY anti-HER-2/neu (4B5) Rabbit Monoclonal …

https://www.fda.gov/medical-devices/recently-approved-devices/pathway-anti-her-2neu-4b5-rabbit-monoclonal-primary-antibody-p990081s047

VENTANA HER2 Dual ISH DNA Probe Cocktail – P190031

https://www.fda.gov/medical-devices/recently-approved-devices/ventana-her2-dual-ish-dna-probe-cocktail-p190031

The VENTANA HER2 Dual ISH DNA Probe Cocktail is a lab test that estimates the number of copies of the HER2 gene in breast cancer tissue samples to …

FDA approves Roche’s new VENTANA HER2 Dual ISH …

https://www.globenewswire.com/news-release/2020/07/29/2069629/0/en/FDA-approves-Roche-s-new-VENTANA-HER2-Dual-ISH-test-as-companion-diagnostic-to-identify-breast-cancer-patients-eligible-for-targeted-therapy.html

The new VENTANA HER2 Dual ISH DNA Probe Cocktail assay is optimised for use with the VENTANA Silver ISH DNP Detection Kit and the VENTANA Red ISH DIG Detection Kit …

Premarket Approval (PMA) - Food and Drug Administration

https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpma/pma.cfm?id=P990081S039

Approval for the Ventana Medical Systems, Inc.'s (Ventana) PATHWAY anti-HER-2/neu (4B5) Rabbit Monoclonal Primary Antibody (PATHWAY HER2 (4B5)) is …

PATHWAY anti-HER2/neu (4B5) Rabbit Monoclonal …

https://diagnostics.roche.com/global/en/products/tests/pathway-anti-her-2-neu-4b5-rabbit-monoclonal-primary-antibody-fda.html

Leading the way in HER2 testing. The use of pre-diluted PATHWAY anti-HER2/neu (4B5) Rabbit Monoclonal Primary Antibody 1 (PATHWAY HER2 (4B5)), in combination with the …

Ventana announces HER2 companion diagnostic to …

https://www.prnewswire.com/news-releases/ventana-announces-her2-companion-diagnostic-to-identify-breast-cancer-patients-for-roches-latest-targeted-medicines-perjeta-and-kadcyla-235720501.html

Ventana Medical Systems, Inc. ("VMSI") (SIX: RO, ROG; OTCQX: RHHBY ), a member of the Roche Group, innovates and manufactures instruments and reagents …

Ventana announces HER2 companion diagnostic | AZBio

https://www.azbio.org/ventana-announces-her2-companion-diagnostic

TUCSON, Ariz., Dec. 13, 2013 /PRNewswire/ — Ventana Medical Systems, Inc. (Ventana), a member of the Roche Group, today announces the VENTANA …

Premarket Approval (PMA) - Food and Drug Administration

https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpma/pma.cfm?id=P100027

the inform her2 dual ish dna probe cocktail is indicated as an aid in the assessment of patients for whom i-herpceptin (trastuzumab) treatment is being …

Ventana Medical Systems - Wikipedia

https://en.wikipedia.org/wiki/Ventana_Medical_Systems

Ventana Medical Systems, Inc. was a medical device company that develops, manufactures, and markets instrument reagent systems that automate tissue and slide …